On August 12, 2016, IBM and Hangzhou Cognitive Network Technology Co., Ltd. (hereinafter referred to as “Hangzhou Cognitionâ€) announced that 21 hospitals in China have planned to use the Memorial Sloan Kettering Memorial Center (Memorial Sloan Kettering). Cancer Center's IBM Watson for Oncology, a collaboration designed to help Chinese doctors gain personalized, evidence-based cancer treatments through cognitive computing platforms. As an important part of the far-reaching cooperation between IBM and Hangzhou, the 21 hospitals that were initially used will be used as demonstrations in the industry to better promote Watson tumor solutions in hospitals across China. This is also the first partner project of Watson Health in China. IBM Watson represents the arrival of a new era of cognitive computing Wang Tianyi, general manager of IBM Greater China, said in his speech that cancer treatment is a very big topic facing humanity. IBM cognitive technology gives machines the ability to learn quickly and understand deeply. In April 2016, the Watson Health Center was established and cooperated with a number of institutions including hospitals, pharmacies, medical imaging companies, insurance companies, and joint research in the field of cancer treatment, and has made great progress. At the same time, IBM also hopes that the previous cooperation can bring useful reference value to the Chinese medical community. IBM icon IBM Watson represents a fundamental shift in the paradigm of computing, and learning systems that are constantly evolving through the processing of vast amounts of knowledge are gradually replacing and becoming dominant in programmable systems. In the past few decades, programmable systems have been one of the mainstream. Based on cutting-edge research by IBM experts, IBM Watson has the ability to read and understand natural language. The Watson Tumor Solution was developed by IBM and is being promoted in conjunction with the world's leading cancer research center, the Memorial Sloan-Kettering Cancer Center. Watson's oncology solutions can extract vast amounts of information, including more than 300 medical journals, more than 200 textbooks, and nearly 15 million pages of text, enabling advice on drug selection and medication options. At the same time, IBM Watson is also able to link to industry-recognized research and clinical guidelines. Its machine learning ability also means that it can continue to learn over time. The diseases covered by the project are lung cancer, breast cancer and colorectal cancer. In April 2015, IBM established the Watson Health Department and launched the Watson Health Cloud Platform. This new division aims to increase the innovation capabilities of doctors, researchers and insurance companies to discover more insights from personal health data created and shared every day. Watson Health Cloud can help share this information and combine it with a dynamic and growing aggregate view from clinical, scientific and social health data. Todd Kalyniuk, vice president of Watson Health and Watson for Oncology, IBM Global, said that at present, the world spends $7.8 trillion annually on implementing health and social security programs, and 30% of every $1 is wasted. The treatment plan is not accurate, and less than half of the drugs have empirical evidence, and it is impossible to solve the problem of population aging and so on. The arrival of IBM Watson is at a time when China faces increasingly serious cancer challenges. For China's 1.4 billion people, cancer is now at the top of the mortality rate. In 2015 alone, there were 4.3 million new cancer cases in China, and more than 2.8 million people died of cancer. About 12,000 new cancer diagnosis cases are expected in China every day. In the future, in the face of a large number of emerging cancer research cases, in order to maintain the use of the best treatment practices, doctors will face increasing pressure from the Japanese. An HGH injection pen is a device used to administer human growth hormone
(HGH) through subcutaneous injections. The pen is designed to be easy
to use, portable, and discreet, making it a popular choice among
individuals who require regular HGH injections for medical reasons, such
as growth hormone deficiency or Turner syndrome. The pen contains a
cartridge of HGH solution and a needle that is inserted into the skin to
deliver the medication. The injection can be adjusted for dosage and
frequency based on individual needs, and the pen is typically reusable
for multiple injections. Hgh Injection Pen,Reusable Hgh Pen Injector,High Performance Pen Injector,Medical Hgh Pen Injector Shanghai Enjosim Medical Technology Co., Ltd , https://www.enjosimmedical.com.jpg)